TerminatedNCT00965419
What is this study about?Researchers are studying Edivoxetine, tracking side effects to assess long-term safety and tolerability in children with ADHD.
This study ended early.
Multiple locations, including Spring ValleyADHDMedication studyAges 6–18
- Countries
- United States, Canada, Taiwan
- Sponsor
- Eli Lilly and Company
CompletedNCT00922636
What is this study about?Researchers compared LY2216684, methylphenidate and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Spring ValleyADHDMedication studyAges 6–17
- Countries
- United States, Canada
- Sponsor
- Eli Lilly and Company
CompletedNCT03615794
Official study titleA Prospective Study of Pregnant and Postpartum Women With and Without Mood Disorders
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreDepression, Bipolarity, ...Observational studyAges 18–50
- Countries
- United States
- Sponsor
- Johns Hopkins University
CompletedNCT03866174
Official study titleA Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)
This study has finished and is no longer accepting participants.
Multiple locations, including San FranciscoDepressionMedication studyAges 21–65
- Countries
- United States
- Sponsor
- Usona Institute
Active Not RecruitingNCT06407635
Official study titlePsilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy
This study is no longer accepting new participants.
In BaltimorePTSDMedication studyAges 21–75
- Countries
- United States
- Sponsor
- Johns Hopkins University
CompletedACTRN12621001097831
What is this study about?This study evaluated the effectiveness of psychotherapy for people with depression.
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Swinburne University of Technology
CompletedNCT00791622
Official study titleA Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating QT/QTc Intervals Following Administration of Extended-release Paliperidone and Quetiapine in Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–50
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
TerminatedNCT03352453
What is this study about?Researchers are comparing Rapastinel and placebo to find out how the approaches affect depression symptoms in adults with depression.
This study ended early.
Multiple locations, including BirminghamDepression, SuicidalityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc